Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device

NCT: NCT05365646 · RECRUITING

NCT IDNCT05365646
StatusRECRUITING
Start Date2022-05-23
Completion2026-10

Brief Summary

The purpose of this study is to develop and validate methods to use hearing aids equipped with embedded sensors and artificial intelligence to assist in the assessment of fall risk and in the implementation of interventions aimed at reducing the risk of falling, as well as to improve speech intelligibility in quiet and in background noise, track physical activity, and social engagement. The investigators hope is that the knowledge that is generated through this study will ultimately translate to the clinical setting and will help reduce the likelihood that individuals experience a fall, and improve the quality of hearing in individuals who wear hearing aids.

Frequently Asked Questions

What is Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device?

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device is a clinical trial registered under NCT05365646. Current status: RECRUITING.

What is the status of NCT05365646?

The current status of NCT05365646 (Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device) is: RECRUITING.

When did Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device start?

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device started on 2022-05-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.